로딩 중…
지수 로딩 중…
Entrada Therapeutics, Inc.
TRDA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$7.09+4.11%
2026-06-18
Price Chart
Entrada Therapeutics, Inc.+0.85%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $275M |
| Revenue | $6M |
| Net Income | $-166M |
| Total Assets | $336M |
| Net Assets | $271M |
| Value | |
| P/B | 1.02x |
| P/S | 47.97x |
| FCF Yield | -47.83% |
| Profitability | |
| ROE | -61.33% |
| ROA | -49.51% |
| Op. Margin | -3109.29% |
| Revenue Growth | -95.74% |
| Earnings Growth | -319.04% |
| Financial Health | |
| Debt Ratio | 23.87% |
| Total Debt | $50M |
| FCF | $-132M |
| Cash | $76M |
| Current Ratio | 13.90x |
| Performance | |
| 1Y Return | 0.85% |
| 1M Return | 25.49% |
| From 52W High | -56.90% |
| 1Y MDD | -64.75% |
| Trading | |
| Volume | 314,300 shares |
| Trading Value | $2M |
| Per Share | |
| EPS | $-3.47 |
| BPS | $7.40 |